FI69845C - Foerfarande foer framstaellning av nya antibakteriella penemderivat - Google Patents

Foerfarande foer framstaellning av nya antibakteriella penemderivat Download PDF

Info

Publication number
FI69845C
FI69845C FI793903A FI793903A FI69845C FI 69845 C FI69845 C FI 69845C FI 793903 A FI793903 A FI 793903A FI 793903 A FI793903 A FI 793903A FI 69845 C FI69845 C FI 69845C
Authority
FI
Finland
Prior art keywords
mmol
solution
ether
mixture
alk
Prior art date
Application number
FI793903A
Other languages
English (en)
Finnish (fi)
Other versions
FI69845B (fi
FI793903A (fi
Inventor
Marcel Menard
Alain Martel
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI793903A publication Critical patent/FI793903A/fi
Priority to FI843981A priority Critical patent/FI70717C/fi
Publication of FI69845B publication Critical patent/FI69845B/fi
Application granted granted Critical
Publication of FI69845C publication Critical patent/FI69845C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI793903A 1978-12-18 1979-12-13 Foerfarande foer framstaellning av nya antibakteriella penemderivat FI69845C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI843981A FI70717C (fi) 1978-12-18 1984-10-10 2-azetidinonderivat foer anvaendning som mellanprodukter vid framstaellning av terapeutiskt anvaendbara penemderivat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96866378A 1978-12-18 1978-12-18
US96866378 1978-12-18

Publications (3)

Publication Number Publication Date
FI793903A FI793903A (fi) 1980-06-19
FI69845B FI69845B (fi) 1985-12-31
FI69845C true FI69845C (fi) 1986-05-26

Family

ID=25514601

Family Applications (2)

Application Number Title Priority Date Filing Date
FI793903A FI69845C (fi) 1978-12-18 1979-12-13 Foerfarande foer framstaellning av nya antibakteriella penemderivat
FI793905A FI67853C (fi) 1978-12-18 1979-12-13 Foerfarande foer framstaellning av nya antibakteriella 7-oxo-4-tia-1-aza-bicyklo(3,2,0)hept-2-enderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI793905A FI67853C (fi) 1978-12-18 1979-12-13 Foerfarande foer framstaellning av nya antibakteriella 7-oxo-4-tia-1-aza-bicyklo(3,2,0)hept-2-enderivat

Country Status (13)

Country Link
JP (1) JPS60222486A (es)
AU (4) AU541717B2 (es)
CA (2) CA1286661C (es)
CH (2) CH643265A5 (es)
DK (5) DK161520C (es)
ES (1) ES487034A0 (es)
FI (2) FI69845C (es)
GR (2) GR81420B (es)
IE (3) IE49877B1 (es)
IL (2) IL58576A (es)
SE (5) SE454779B (es)
YU (4) YU43628B (es)
ZA (2) ZA796812B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8509180D0 (en) * 1985-04-10 1985-05-15 Erba Farmitalia Penem derivatives
US4826832A (en) * 1986-05-06 1989-05-02 Ciba-Geigy Corporation Penen compounds
ATE253070T1 (de) * 1995-02-17 2003-11-15 Daiichi Suntory Pharma Co Ltd Penem-derivate und sie enthaltende anti- mikrobische mittel
US6365635B1 (en) 1998-01-13 2002-04-02 Suntory Limited Antibacterial composition for topical administration containing antibiotic
JP2005239696A (ja) 2004-01-30 2005-09-08 Daiichi Suntory Pharma Co Ltd 無機物質を配合した医薬硬質カプセル剤
CN112746066B (zh) * 2021-01-25 2023-10-31 洛阳华荣生物技术有限公司 一种l-赖氨酸脱羧酶突变体及其应用

Also Published As

Publication number Publication date
YU42125B (en) 1988-04-30
IL58576A (en) 1985-12-31
SE464027B (sv) 1991-02-25
SE8405813D0 (sv) 1984-11-19
SE448995B (sv) 1987-03-30
SE8405719D0 (sv) 1984-11-14
DK135291D0 (da) 1991-07-15
FI69845B (fi) 1985-12-31
FI793903A (fi) 1980-06-19
GR81420B (es) 1984-12-11
YU307679A (en) 1983-02-28
AU541717B2 (en) 1985-01-17
DK236590D0 (da) 1990-10-01
CA1268183A (en) 1990-04-24
DK161520C (da) 1991-12-23
ZA796812B (en) 1981-05-27
IE852246L (en) 1980-06-18
ZA796813B (en) 1981-05-27
DK161970C (da) 1992-02-03
YU43464B (en) 1989-08-31
YU215782A (en) 1983-06-30
SE8405812D0 (sv) 1984-11-19
AU539983B2 (en) 1984-10-25
IE792462L (en) 1980-06-18
DK533779A (da) 1980-06-19
IL58576A0 (en) 1980-01-31
FI793905A (fi) 1980-06-19
DK135291A (da) 1991-07-15
SE8405813L (sv) 1984-11-19
SE8405719L (sv) 1984-11-14
FI67853C (fi) 1985-06-10
IE50597B1 (en) 1986-05-28
CH643265A5 (en) 1984-05-30
GR74491B (es) 1984-06-28
SE7910390L (sv) 1981-06-18
IE851853L (en) 1980-06-18
AU3240884A (en) 1984-12-13
FI67853B (fi) 1985-02-28
IE49877B1 (en) 1986-01-08
CH643846A5 (en) 1984-06-29
DK161520B (da) 1991-07-15
DK237690D0 (da) 1990-10-01
YU43628B (en) 1989-10-31
AU3288484A (en) 1985-03-07
JPS60222486A (ja) 1985-11-07
YU276079A (en) 1983-02-28
CA1286661C (en) 1991-07-23
IL58804A0 (en) 1980-02-29
AU5378779A (en) 1980-08-28
IE49876B1 (en) 1986-01-08
SE8405812L (sv) 1984-11-19
IL58804A (en) 1986-03-31
DK236590A (da) 1990-10-01
SE7910391L (sv) 1981-06-18
AU5371079A (en) 1980-06-26
DK237690A (da) 1990-10-01
AU557545B2 (en) 1986-12-24
AU563015B2 (en) 1987-06-25
YU215382A (en) 1983-06-30
YU43280B (en) 1989-06-30
DK161970B (da) 1991-09-02
ES8101594A1 (es) 1980-12-16
DK533879A (da) 1980-06-19
SE454779B (sv) 1988-05-30
ES487034A0 (es) 1980-12-16
SE461395B (sv) 1990-02-12

Similar Documents

Publication Publication Date Title
EP0071908B1 (en) 1-, and 1,1-disubstituted-6-substituted-2-carbamimidoyl-1-carbadethiapen-2-em-3-carboxylic acids, a process for preparing and an antibiotic composition containing the same
JPH0215552B2 (es)
GB2042514A (en) Antibacterial agents
HU182017B (en) Process for preparing 6-substituted thia-aza-derivatives
JPS61207387A (ja) 抗菌剤
JP4252628B2 (ja) 三環型カルバペネムのエチリデン誘導体
EP0037082B1 (en) Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
KR880002512B1 (ko) 페넴 화합물 및 이의 제조방법
KR880001069B1 (ko) 카르바페넴 유도체및 그의 제조방법
FI69845C (fi) Foerfarande foer framstaellning av nya antibakteriella penemderivat
FI85707B (fi) Foerfarande foer framstaellning av nya penemfoereningar.
US4675317A (en) 2-unsaturated alkylthio-pen-2-em-3-carboxylic acids
NL8102736A (nl) Penem-3-carbonzuurverbindingen en hun bereiding.
FI77662B (fi) Foerfarande foer framstaellning av nya antibakteriella penemderivat.
CA1136617A (en) 2,6-disubstituted penem compounds
JPH0516433B2 (es)
EP0235823B1 (en) Carbapenem antibiotics, a process for preparing them and pharmaceutical compositions containing them
JPH0532668A (ja) 置換2−チオキソペナムおよび2−置換チオペネムの製造方法
SE460197B (sv) Nya karbapenemderivat och foerfarande foer framstaellning daerav
JPS62270588A (ja) ペネム誘導体
US5183887A (en) Spirocyclic 6-amido-carbapenems and azetidinones
US4837215A (en) Penem derivatives
FI80702B (fi) Foerfarande foer framstaellning av antibakteriella tio-penem-3-karboxylsyror.
JPH045037B2 (es)
JPH0224832B2 (es)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO